10x Genomics (TXG) - Company Sales

Corporate emblem and logo of 10x Genomics (TXG)

10x Genomics, Inc. (TXG) develops DNA analysis technologies, generating revenue through the sale of systems and high-margin reagents. The company's sales metrics currently reflect a level of approximately 0.62, illustrating daily revenue. Demand here is non-cyclical and relies on medical budgets; however, limited cash flow requires management to maintain strict control over internal reserves to sustain liquidity.

10x (TXG) Company Sales: for the period 07/04/2022 - 11/15/2026

Analytical breakdowns for 10x Genomics, Inc.

- market value and analyst target forecast:
Summary company analysis:TXG 10x Genomics
Manufactured product of 10x

This indicator aggregates daily product revenue, filtering out market noise to reveal the true dynamics of income. For 10x Genomics, Inc. (TXG), this sales trajectory confirms demand for analysis systems within the academic sector. The decelerating sales pace of consumables necessitates an analysis of distribution efficiency. A stable trend in the company's sales trajectory indicates an expansion of market share. Sufficient liquidity provides business resilience.

Competing companies

Tempus AI, Inc. (TEM) - Company Gross Revenue|Company Sales QGEN (Qiagen NV)|Revenue and Sales Volume Ionis Pharmaceuticals, Inc. (IONS)|Revenue and Sales Volume RGEN (Repligen Inc.)|Avidity Corp (RNA) - Company Total Revenue|CRSP - Company Revenue|Company Gross Revenue genedx.com WGS|Ultragenyx Pharmaceutical (RARE) - Company Revenue|Company Total Revenue Beam Therapeutics Corp (BEAM)|SRPT (Sarepta Therapeutics) - Revenue and Sales Volume|Company Total Revenue Twist Bioscience Corp TWST|Revenue and Sales Volume NTLA|Revenue and Sales Volume Stoke Therapeutics, Inc. (STOK)|Company Revenue BioLife BLFS|WVE - Company Sales|Maze Therapeutics Corp - Revenue and Sales Volume|Sionna Pharma - Company Total Sales|Prime Medicine (PRME) - Company Revenue|tayshagtx.com (TSHA) - Revenue and Sales Volume|Company Revenue uniQure Corp|MGTX: Company Sales Revenue|Revenue and Sales Volume RGNX|Company Gross Revenue Solid Corp|Revenue and Sales Volume OCGN (ocugen.com)|PACB (Pacific Biosciences) - Company Annual Revenue|Benitec Biopharma Inc - Revenue and Sales Volume|Company Gross Revenue Design Therapeutics, Inc. DSGN|Rocket Corp (RCKT) - Company Revenue|4D Molecular Therapeutics (FDMT) - Revenue and Sales Volume|LXEO (Lexeo Therapeutics, Inc.) - Revenue and Sales Volume|Company Total Revenue korrobio.com KRRO|Company Sales EDIT (Editas Medicine, Inc.)|Silence Therapeutics plc - Company Sales Volume|Company Revenue ProQR Therapeutics N.V. PRQR|Company Gross Revenue Codexis, Inc. (CDXS)|SGMO - Company Revenue|nautilus.bio - Company Total Sales|Metagenomi, Inc (MGX) - Company Revenue|Company Sales Volume DTIL|Company Revenue Generation Bio|Revenue and Sales Volume Boundless Bio Inc|Company Revenue Exicure Corp (XCUR)|Company Gross Revenue Imunon|Revenue and Sales Volume PHIO (phiopharma.com)|Company Total Sales Volume mustangbio.com|RNAZ - Company Revenue|Company Total Revenue Bionano Genomics|APDN: Revenue and Sales Volume|Company Sales Volume BLUE|Company Sales IPA|OMGA: Company Sales Revenue|Revenue and Sales Volume OMIC|Company Gross Revenue Regulus Therapeutics|Company Revenue Syros SYRS|Company Sales Revenue TBIO|TCON: Company Sales|Unity Biotechnology, Inc. (UBX) - Company Sales